ARCHIVES

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995